TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

CUSIP: 89455T109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common stock, $0.001 par value
Shares outstanding
63,703,704
Total 13F shares
35,535,142
Share change
+7,262,145
Total reported value
$895,139,591
Put/Call ratio
12%
Price per share
$25.19
Number of holders
122
Value change
+$184,017,260
Number of buys
88
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q1 2023

As of 31 Mar 2023, TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,535,142 shares. The largest 10 holders included VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., PERCEPTIVE ADVISORS LLC, NEXT CENTURY GROWTH INVESTORS LLC, CIBC Private Wealth Group, LLC, EMERALD ADVISERS, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, LOOMIS SAYLES & CO L P, and NORGES BANK. This page lists 122 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.